The structure of the LDL protein apoB100
At the University of Missouri, Zachary Berndsen and Keith Cassidy used AlphaFold to predict the structure of apoB100, the scaffold of LDL particles, and refined it using cryo-electron microscopy data. The result is a cage-like shell with a ribbon belt. The post gives no figures such as resolution and no clinical validation.
Technology: AlphaFold
Family AlphaFold: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Cryo-EM images were refined with AlphaFold2 predictions; the resulting apoB100 structure was compared with more than 200 intramolecular cross-links and showed close agreement, with subnanometre resolution in most regions.
- Still unknown: The article states that clinical applications will take time and the structure's implications are not yet realized; it gives no resolution figures or clinical validation, and the abstract states that resolution is subnanometre only in most regions.
- AI role: AlphaFold2 generated the initial atomic-resolution structure predictions, which were refined against cryo-EM data.
Evidence sources: https://deepmind.google/blog/revealing-a-key-protein-behind-heart-disease/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41586-024-08467-w&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: blog. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 48 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.